Your browser doesn't support javascript.
loading
The effects of troglitazone on AMPK in HepG2 cells.
Allen, Katherine M; Coughlan, Kimberly A; Mahmood, Fabliha N; Valentine, Rudy J; Ruderman, Neil B; Saha, Asish K.
Affiliation
  • Allen KM; Endocrinology, Diabetes, and Nutrition Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
  • Coughlan KA; Endocrinology, Diabetes, and Nutrition Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
  • Mahmood FN; Endocrinology, Diabetes, and Nutrition Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
  • Valentine RJ; Endocrinology, Diabetes, and Nutrition Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
  • Ruderman NB; Endocrinology, Diabetes, and Nutrition Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
  • Saha AK; Endocrinology, Diabetes, and Nutrition Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA. Electronic address: aksaha@bu.edu.
Arch Biochem Biophys ; 623-624: 49-57, 2017 06 01.
Article in En | MEDLINE | ID: mdl-28526426
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Chromans / Thiazolidinediones / Diabetes Mellitus, Type 2 / Enzyme Activation / AMP-Activated Protein Kinases / Hypoglycemic Agents Limits: Humans Language: En Year: 2017 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Chromans / Thiazolidinediones / Diabetes Mellitus, Type 2 / Enzyme Activation / AMP-Activated Protein Kinases / Hypoglycemic Agents Limits: Humans Language: En Year: 2017 Type: Article